Introduction
HIV-associated nephropathy (HIVAN) predominantly occurs in patients with African-American descent. It is characterized by heavy proteinuria, rapidly progressive renal failure, and distinct morphological features in the form of collapsing focal segmental glomerulosclerosis (FSGS) and microcystic tubular dilatation [1] . Although a variety of cytokines are released during HIV infection, HIV infection of kidney cells including both glomerular and tubular epithelilal cells plays a critical role of for the development and progression of HIVAN [2, 3] .
Podocytes are specialized, terminally differentiated visceral epithelial cells in the Bowman's capsule in the kidney. They wrap around capillaries of the glomerulus, and extend foot processes to form the blood urine filtration barrier, and are directly implicated in the integrity of the glomerular basement membrane [4, 5] . Podocytes play a key role in maintaining the filtration barrier in kidney, and their injury or damage has been linked to the development of proteinuria as well as the progression of chronic kidney disease [6] . We and other investigators have shown that HIV could infect podocytes leading to kidney cell injury in the form of dedifferentiation and proliferation [7] [8] [9] [10] [11] [12] [13] .
Epithelial mesenchymal transition (EMT) is a process in which epithelial cells lose their epithelial phenotype and attain characteristic features of mesenchymal cells such as proliferation and migration. It has been widely recognized that renal tubular epithelial cells are able to undergo EMT under pathological conditions [14] [15] [16] [17] [18] [19] . In vitro and in vivo studies show that after treatment with fibrogenic cytokines such as TGF-β, tubular epithelial cells usually lose epithelial markers, including E-cadherin and ZO-1, and acquire mesenchymal markers such as vimentin, α-SMA, FSP1, and fibronectin [20] . Our previous studies also displayed occurrence of EMT in tubular cells in HIVAN (Tg26) mice [21, 22] . Besides tubular cells, recent evidences have shown that podocytes can also undergo EMT in some pathological conditions [20, [23] [24] [25] [26] . For example, Li et al. reported that EMT was observed in the podocytes in human diabetic kidneys [23] . They also found that TGF-β1 treatment not only suppress epithelial P-cadherin and ZO-1 expression in podocytes but also impairs the filtration barrier function of podocytes [23] . The occurrence of EMT in glomerular epithelial cells manifests in the form of proliferation, migration, matrix synthesis, and loss of their original function and eventually contributing to fibrosis.
The Hedgehog signaling pathway (hedgehog pathway) is a evolutionarily conserved pathway, which is essential for regulating a diverse array of biologic processes, such as embryonic development, tissue homeostasis, injury repair, and tumorigenesis [27, 28] . This pathway starts from hedgehog homologues binding to their special receptor Patched (PTCH) in the plasma membrane, resulting in the de-repression of smoothened (SMO) [29, 30] . Activated smoothened changes its position from an intracellular vesicle to the cell membrane where the Gli family of transduction factors are activated. Subsequently, the activated Gli proteins enter the nucleus and initiate the transcription of their target genes. Several of its own major components, including Gli1, PTCH, and hedghog interacting protein 1 (Hhip 1), are also the direct transcriptional targets of hedgehog pathway, which provides both positive and negative feedback to ensure the delicate regulation of this system. Among these molecules, Gli1 is the principal downstream target and mediator of hedgehog signaling. Mammals have three hedgehog homologues, Dhh, Ihh, and Shh, of which Sonic (Shh) is the most widely studied and best characterized.
Hedgehog pathway has been reported to regulate EMT in cancer cells [31, 32] . It also mediates the EMT in renal tubular cells and promotes fibrosis [32, 33] . Whether hedgehog pathway is involved in the podocyte injury or not is not yet clear. Since HIV has been reported to modulate hedgehog pathway in T lymphocyte [34] , we speculate that it may have similar effects in podocyte. We hypothesize that HIV enhances podocyte EMT through hedgehog pathway activation.
Materials and methods

Reagents
Recombinant hedgehog (Shh) was purchased from R & D System (Minneapolis, MN), while Gant 58 was purchased from Tocris Bioscience (Ballwin, MO).
Animal experiments
All animal experiments complied with Institutional Animal Care and Use Committee (IACUC)-approved protocols (approval #2009-012). FVB/N and Tg26 mice (FVB/N background) purchased from Jackson Laboratory (Bar Harbor, ME, USA), were housed within the rodent holding facilities in the Feinstein Institute for Medical Research (Northwell Health) in Manhasset, New York. Three male and three female mice at 8 weeks old were used in this study.
Culture of human podocytes
Human podocytes were cultured as previously reported [35] [36] [37] . Briefly, immortalized human podocytes proliferated in the growth medium containing RPMI 1640 supplemented with 10% fetal bovine serum, 1 X penicillin-streptomycin, 1 mM L-glutamine, and 1 X insulin, transferrin, and selenium (ITS) (Invitrogen, Grand Island, NY) at permissive temperature (33°C). When the cells reached about 80% confluence, they were transferred to 37°C for differentiation in a medium without ITS for 7 days.
Real time-PCR
Total RNA was isolated from mouse kidney tissue or human podocytes using Trizol reagent (Invitrogen). Five micrograms of total RNA were reverse transcribed using the first-strand synthesis system (Invitrogen). Real time-PCR was performed in a Prism 7900HT sequence-detection system (Applied Biosystems, Foster City, CA, USA). Relative mRNA levels were determined and standardized with a GAPDH internal control using comparative ΔΔCT method. Sequences of primers for the targeting genes are listed in Table 1 .
Gli1 overexpression
Human podocytes (5×10 5 ) were cultured in 100 mm dish. After differentiation for 7 days, the cells were transfected with 3 μg TAL2271-Gli1 plasmid (Addgene, Cambridge, MA) by using the Effectene Transfection Reagent (Qiagen, Germantown, MD) following the manufacturer's instruction.
Western blot analysis
Western blotting was performed using established methodology [36] [37] [38] [39] [40] [41] . Briefly, cells were washed with PBS and lysed in RIPA buffer (1 X PBS, pH7.4, 0.1% SDS, 1% NP-40, 0.5% sodium deoxycholate, 1.0 mM sodium orthovanadate, 10 μl of protease inhibitor cocktail (100 x, Calbiochem) per 1 ml of buffer, and 100 μg/ml PMSF). Proteins (20-30 μg) were separated by 12% SDS-polyacrylamide gel electrophoresis (PAGE) and then transferred on an Immuno-Blot polyvinylidene fluoride (PVDF) membrane (Bio-Rad, Hercules, CA). After blocking in PBS/Tween (0.1%) with 5% nonfat milk, the membrane was incubated with primary antibodies overnight at 4°C followed by horseradish peroxidase-conjugated secondary antibodies (Santa Cruz, 1:3000) and then developed using Enhanced Chemiluminescent (ECL) solution (Pierce). Primary antibodies used were rabbit anti-Shh, (Cell Signaling Technology, 1:1000), rabbit anti-PTCH (Santa Cruz, 1:1000), rabbit anti-Gli1 (Santa Cruz, 1:1000), rabbit anti-P-Cadherin (Santa Cruz, 1:1000), rabbit anti-Vimentin (Santa Cruz, 1:1000), rabbit anti-α-SMA (Santa Cruz, 1:1000), mouse anti-Fibronectin (Santa Cruz, 1:1000), rabbit anti-Snail (Santa Cruz, 1:1000), and goat anti-actin (Santa Cruz, 1:3000). For protein expression quantification, the films were scanned with a CanonScan 9950F scanner and the acquired images were then analyzed using the public domain NIH image program (http://rsb.info.nih.gov/nih-image/).
Pseudo-types HIV transduction
Replication defective HIV viral supernatants were prepared and transduced into human podocyte as published previously [39] [40] [41] . In brief, GFP reporter gene was substituted for gag/pol genes in HIV-1 proviral construct pNL4-3. This parental construct (pNL4-3:ΔG/P-GFP) was used to produce VSV. G pseudotyped viruses to provide pleiotropism and high-titer virus stocks. Infectious viral supernatants were produced by the transient transfection of 293 T cells using effectene (Qiagen Inc., Valencia, CA) according to the manufacturer's instructions. The HIV-1 gag/pol and VSV.G envelope genes were provided in trans using pCMV R8.91 and pMD.G plasmids, respectively. As a negative control, virus was also produced from pHR-CMV-IRES2-GFP-ΔB, which contained HIV-1 LTR and GFP empty expression vector. The viral stocks were titrated by infecting HeLa cells with tenfold serial dilution as reported previously [39] . Differentiated human podocytes were transduced with these psedo-typed HIV (titrated as 0.8 pg HIV p24 protein per cell) for 3 h, followed by culture in fresh medium.
Albumin influx assay
A simple albumin influx assay was used to evaluate the filtration barrier function of podocyte monolayer, as described by Li et al. with some modifications [23] . Briefly, podocytes (5×10 and treated without or with SHH or HIV for a certain period. Cells were washed twice with PBS supplemented with 1 mM MgCl2 and 1 mM CaCl2. The top chamber was then refilled with 0.5 ml of RPMI 1640 and the bottom chamber with 2 ml of RPMI 1640 supplemented with 40 mg/ml of bovine serum albumin and incubated at 37°C. A small aliquot of media from the top chamber was collected at different time intervals and albumin concentration was determined.
Statistical analyses
Data were presented as means ± standard deviation (SD) unless otherwise noted. All experiments were repeated at least three times with duplicate or triplicate samples in each assay. All data were evaluated statistically by the analysis of variance (ANOVA), followed by Nweman-Keuls multiple comparison tests using software (Prism 4.0, GraphPad Software). In the case of single mean comparison, data were analyzed by t-test. P values < 0.05 were considered as statistically significant.
Results
HIV activates hedgehog pathway in podocytes
We examined whether HIV infection activates hedgehog pathway in human podocytes. We transduced differentiated human podocytes with pseudo type HIV for 12, 24, 48, and 72 h, and then extracted total RNA for real time-PCR. Results showed that the mRNA levels of Shh, Dhh, Ihh, Gli1, and PTCH, were dramatically increased in a time course effect (Fig. 1A) . For protein expression, cellular lysates (collected after 48 h) were subjected to Western blotting. HIV-transduced podocytes displayed enhanced expression of Shh, Gli1, and PTCH (Figs. 1B-1D ) indicating that hedgehog pathway was activated by HIV in human podocytes.
We then evaluated the expression of these factors in the kidneys of Tg26 as well as control (FVB/N) mice. Renal tissues were used for real time-PCR and Western blot analysis. mRNA expressions of hedgehogs (Dhh, Ihh, Shh), Gli1, and PTCH were significantly increased in Tg26 mice when compared with control mice (Fig. 2A) ; Western blot analysis also revealed increased expression of Gli1 and PTCH in renal tissues of 
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Fig. 3. Overexpression of Gli1 enhances EMT in podocyte.
Human podocytes were transfected with TAL2271-Gli1 plasmid or empty vector (control) and were then cultured fresh medium. Cells were harvested after 24 h, lysates were subjected to Western blotting to examine the changes of hedgehog pathway and EMT markers. A. Representative gels are displayed. B. Quantification of the expression of Gli1, Fibronectin, P-cadherin, vimentine, α-SMA, and Snail, in A, and the results (mean ± SD) represent three independent samples. * p < 0.05 when compared with the control vector.
Fig. 4. Shh activates hedgehog pathway and induces EMT at different time points.
Human podocytes were treated with recombinant Shh (100 ng/ml) for 6, 12, 24, and 48 h, and the cell lysates were collected for Western blotting to examine the changes of hedgehog pathway and EMT markers. A. Representative gels are displayed. B. Quantification of the expression of Gli1, vimentine, and α-SMA in A, and the bar graphs (mean ± SD) represent three independent samples. * p < 0.05 when compared with the control of starting time (0 h).
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Tg26 mice (Fig. 2B-C) . These results indicated that hedgehog pathway was activated in the kidney of Tg26 mice.
To further examine the activation of hedgehog pathway in HIV milieu, we performed immunofluorescent staining in renal cortical sections of control and Tg26 mice. Results showed enhanced podocyte expression of PTCH in Tg26 mice when compared FVB/N (control) mice (Figs. 2E and 2F) . The results also showed that some PTCH colocalized with synaptopodin, a protein marker for podocytes. Taken together, these results clearly demonstrate that hedgehog pathway in podocytes is activated by HIV.
Hedgehog pathway activation enhances EMT in podocytes
To determine the effect of hedgehog pathway activation on EMT in Fig. 5 . Shh activates hedgehog pathway and induces EMT in a dose-dependent manner. Human podocytes were treated with 5, 10, 50, or 100 ng/ml of recombinant Shh for 48 h, then the cell lysates were subjected to Western blotting to examine the changes of hedgehog pathway and EMT markers. A. Representative gels are displayed. B. Quantification of the expression of PTCH, Gli1, P-cadherin, vimentine, and α-SMA in A, and the bar graphs (mean ± SD) represent three independent samples. * p < 0.05 when compared with the control (0 ng/ml). Fig. 6 . Blocking hedgehog pathway attenuates HIV-induced EMT in podocyte. Human podocytes were transduced with pseudo-typed HIV for 3 h, and cultured in the medium containing hedgehog inhibitor Gant 58 (10 μM) for 48 h. Cell lysates were collected for Western blotting to examine the changes of EMT markers. A. Representative gels are displayed. B. Quantification of the expression of fibronectin, vimentine, and α-SMA in A, and the bar graphs (mean ± SD) represent three independent samples. * p < 0.05 when compared with the vector control without the addition of Gant 58; while # p < 0.05 when compared with the HIV transduction without the addition of Gant 58.
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podocytes, we overexpressed Gli1 in human podocytes. Results showed that Gli1 was successfully expressed, which subsequently decreased the epithelial protein P-cadherin, but significantly increased the mesenchymal proteins fibronectin, vimentin, and α-SMA (Fig. 3) . Overexpression of Gli1 also increased the expression of Snail, a protein robustly promotes EMT. These results suggest that increasing upregulating Gli1 enhances EMT in podocytes.
To verify this observation, we treated human podocytes with 100 ng/ml recombinant Shh for 6, 12, 24, and 48 h. The expression of Gli1 increased as a function of time course intervals, indicating that hedgehog pathway was activated (Fig. 4) . Meanwhile, Shh also increased vimentin and α-SMA indicating that EMT was induced by addition of Shh.
To further confirm this observation, we treated human podocytes with 5, 10, 50, or 100 ng/ml recombinant Shh for 48 h. We found that the expression of PTCH and Gli1 increased following the increasing concentration of Shh (Fig. 5) . Correspondingly, the expression of vimentin and α-SMA also increased with the increasing Shh concentrations; however, P-cadherin expression decreased. These results indicate that Shh activates hedgehog signaling pathway and induces podocyte EMT in a dose-dependent manner.
Taken together, these results clearly demonstrated that activating hedgehog pathway causes EMT in podocyte.
HIV induces EMT of in podocytes via hedgehog pathway
In our previous studies, we have found that HIV can induce EMT in kidney proximal tubular cells [21, 22] . To determine its effect on podocyte EMT, we transduced human podocytes with pseudo type HIV. We also added Gant 58, an inhibitor of hedgehog pathway, in the medium to examine whether hedgehog pathway is involved in this process. Results showed that HIV dramatically increased the expression of mesenchymal markers, including fibronectin, vimentine, and α-SMA; while addition of Gant 58, significantly decreased their expression (Fig. 6) . These results indicate that hedgehog pathway plays an important role in HIV-induced EMT in podocytes.
Hedgehog pathway activation increases the permeability of podocytes
Li et al. reported that enhanced EMT in podocyte impairs the filtration barrier function of podocytes [23] . To investigate the role of hedgehog pathway in the dysfunction of podocytes, we treated human podocytes with recombinant Shh for 48 h, and then examined the permeability of podocytes by determining the albumin flux. Results showed that Shh-treated podocytes had higher albumin flux at 2 h and 4 h intervals (Fig. 7) , indicating an increase in their permeability.
To detect the role of hedgehog pathway in HIV-induced alteration in protein permeability, we added hedgehog blocker Gant 58 to the podocytes immediately after the HIV transduction. Albumin flux assay results showed that addition of Gant 58 significantly attenuated HIVenhanced podocyte permeability as the albumin flux decreased (Fig. 8 ).
Discussion
Hedgehog pathway activation has been reported in renal tubular and mesangial cells [33, [42] [43] [44] , and it plays an important role in kidney fibrosis; however, its role in the maintenance of podocyte integrity has not been investigated. In this study, we performed both in vitro and in vivo experiments, and found that HIV increases the expression of Gli1 and PTCH in podocytes, demonstrating that hedgehog pathway is activated in podocytes in HIV milieu. Addition of Shh or overexpression of Gli1 significantly decreased the expression of Pcadherin, while increased fibronectin, vimentin, Snail, and α-SMA, indicating that activation of hedgehog pathway stimulates EMT in podocytes. Addition of Shh or transduction of HIV also increased the permeability of podocytes, while hedgehog pathway inhibitor Gant 58 partially attenuated this impairment. All these findings demonstrate that HIV promoted EMT in podocytes via activation of hedgehog pathway. This is the first report to demonstrate the role of hedgehog pathway in podocyte injury.
Although it has been demonstrated that hedgehog signaling pathway can be activated by various viruses such as hepatitis B virus [45] , hepatitis C virus [46] , Epstein-Barr virus [47, 48] , and human papillomavirus [49] , there is hardly any data on the role of HIV in the Fig. 7 . Shh increases podocyte permeability. Human podocytes were cultured on the membrane of transwell with 3 µm pores, and were treated with 100 ng/ml Shh for 48 h. Then the permeability of the membrane was analyzed by testing the albumin influx. * p < 0.05. Fig. 8 . Hedgehog pathway inhibitor decreases HIV-increased podocyte permeability. Human podocytes were cultured on the membrane of transwell with 3 µm pores for 7 days. Pseudo-typed HIV was then transduced for 3 h, and then hedgehog inhibitor Gant 58 (10 μM) was added. After another 3 days, the permeability of the membrane was determined by testing the albumin influx. * p < 0.05. Fig. 9 . Schematic for the role of hedgehog pathway in HIV-induced podocyte EMT. HIV infection increases the production of hedgehog homologues (Dhh, Ihh, and Shh) in podocyte. The hedgehogs were released out of the cell, and bind to their receptor PTHC in the plasma membrane, which further leads to the de-repression of smoothened (SMO). The activated SMO changes its position from an intracellular vesicle to the cell membrane, where it activates the Gli family of transduction factors such as Gli1. The activated Gli proteins subsequently enter the nucleus and start the transcription of their object genes, causing the epithelial mesenchymal transition (EMT) of podocyte. The consequence of podocyte EMT is to increase its permeability and to decrease its filtration function.
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Experimental Cell Research 352 (2017) [193] [194] [195] [196] [197] [198] [199] [200] [201] activation of this pathway [34] . In this study, HIV-infected podocytes displayed enhanced expression of hedgehog homologues (Dhh, Ihh, and Shh), Gli1, and PTCH. Moreover, renal tissues from HIV-trangenic (Tg26) mice also exhibited enhanced expression of all these molecules. These results strongly suggest that HIV also activates hedgehog signaling pathway. Since HIV increases the expression of hedgehog homologues in podocytes, it indicates that an autocrine hedgehog secretion and hedgehog signaling activation loop exists in podocytes.
Since tubule-derived Shh has been reported to mediate epithelialmesenchymal communication by targeting interstitial fibroblasts after kidney injury [42] , we speculate that podocyte-secreted Shh may also act on adjacent renal fibroblasts and mesenchymal cells, leading to the proliferation/fibrosis of these cells. It will be interesting to investigate the role of hedgehog pathway in HIV-induced kidney fibrosis in future studies. Hedgehog signaling pathway plays an important role in the EMT of cancer cells as well as renal tubular cells [31] [32] [33] . In this study, we observed that overexpressing Gli1, or stimulating human podocytes with Shh significantly activated hedgehog pathway, and an increase in the expression of vimentin, α-SMA, and Snail, but decreased expression of P-cadherin. These results suggest that activation of hedgehog pathway may also cause EMT in podocytes.
The consequence of enhanced EMT in renal tubular cells is to increase their fibrotic potential [14] [15] [16] [17] [18] [19] [20] 50, 51] ; for podocytes, EMT increases its impermeability and compromises filtration barrier [23] [24] [25] [26] . In this study, we found that Shh treatment significantly increased the permeability of human podocytes in the form of higher albumin flux. These results suggest that hedgehog pathway regulated podocyte EMT also mediates their permeability.
HIV infection has been demonstrated to cause podocyte injury through many factors, such as vascular endothelial cell growth factors (VEGFs), fibroblast growth factor-2 (FGF-2), IL-1β, TNF-α, angiotensin II (Ang II), Interferon (IFN)-α and IFN-β [52] [53] [54] [55] [56] [57] [58] . These factors impair podocyte homeostasis through activating different signaling pathways. Additionally, we demonstrate a new signaling pathway. We found that in podocytes, HIV significantly increased the production of hedgehog homologues including Shh, Dhh, and Ihh, which subsequently activate the hedgehog signaling pathway. The hedgehog pathway inhibitor Gant 58 obviously attenuated HIV-induced podocyte EMT, as well as decreased impermeability. All these results clearly demonstrated that HIV induces podocyte EMT at least partially through activating hedgehog pathway.
In conclusion, we have demonstrated that HIV activates hedgehog signaling pathway in podocytes, which further enhances EMT, increases its impermeability, and compromises filtration barrier (see schematic in Fig. 9 ). Our study provides insight into new mechanisms involved in HIV-induced podocyte damage, and highlights some new therapeutic targets for HIVAN.
